Clinical Trials Browser

Pancreatic cancer, adult × Gemcitabine × 1 year × Clear all

NCT07436741 2026-02-27

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic cancer, adult

NCT06584227 2025-12-08

ACPC

Phase 2 Recruiting

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT03854110 2025-09-11

Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic cancer, adult

NCT01834235 2025-05-07

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Phase 1/2 Terminated

81 enrolled 13 charts

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms